Background
==========

Listeriosis is a food borne disease caused by the bacterium *L. monocytogenes*. In otherwise healthy individuals, listeriosis is usually asymptomatic or may results in mild flu-like symptoms or gastrointestinal illness. However, infection with *L. monocytogenes* in pregnant women, neonates and immuno-compromised adults can result in a severe and life threatening invasive form of listeriosis. In Europe, after a decline in the number of cases during the 1990s, the incidence of listeriosis increased and has remained relatively high for the past ten years. This has led to listeriosis being considered one of the resurgent foodborne diseases in Europe \[[@B1],[@B2]\]. This disease is rare but associated with a high fatality rate (20-30%) and currently remains an important public health concern.

Based on its genetic content, *L. monocytogenes* can be separated into 3 lineages I, II and III. Although 13 serotypes have been described, 98% of strains causing human infections and isolated from foods are of serotypes 4b, 1/2b (Lineage I), 1/2a, and 1/2c (lineages II) \[[@B3]\]. Molecular methods have been developed to assist in the characterization of *L. monocytogenes.* Doumith et al. (2004) \[[@B4]\] have described a multiplex PCR assay which cluster *L. monocytogenes* of lineages I and II into four serogroups: IVb (4b, 4d, 4e); IIa (1/2a, 3a), IIb (1/2b, 3b, 7) and IIc (1/2c, 3c).

Of several molecular methods currently available, macrorestriction analysis by PFGE is one of the most used methods for the subtyping of *L. monocytogenes*\[[@B5],[@B6]\]. The combination of restriction endonucleases *Asc*I and *Apa*I, as advised by PulseNet USA, has shown excellent discrimination for *L. monocytogenes*\[[@B5]\] and the technique is shown to be reproducible. PFGE, using these two enzymes, is considered to be the international standard for subtyping \[[@B7]\].

AFLP is a method which combines the digestion of the entire bacterial genome by one or more restriction enzymes, with PCR being used to amplify and detect the digested fragments. Fluorescent AFLP is a variant using fluorescent PCR primers, enabling the amplified digested fragments to be detected and sized accurately by capillary electrophoresis. Various fAFLP assays have previously been developed for subtyping *L. monocytogenes* and other *Listeria* spp isolated from food, animals, food processing environment \[[@B8]\] and human cases \[[@B9],[@B10]\]. These assays have been described as reproducible and high resolution genotyping techniques that require less time to perform and to analyze than PFGE. Recently, fAFLP with the enzyme pair *Hind*III/*Hha*I was applied to *L. monocytogenes* isolates from foods and the environment \[[@B11]\], using adaptors and primers previously designed \[[@B12]\] for typing *Campylobacter* isolates. This enzyme pair was found to be more suitable for *L. monocytogenes* than the *BamH*1/*EcoR*I pairs \[[@B13]\]. To our knowledge, these authors have compared, for the first time, fAFLP with PFGE combined with the two enzymes *Apa*I/*AscI* and demonstrated that the discrimination index (DI) of fAFLP was at least equal to PFGE. However, the strain panel only included field strains isolated from food and food processing environments and not human clinical isolates.

ANSES's Laboratory for Food safety has been the EURL for *L. monocytogenes* in the food chain since 2006. *Apa*I/*AscI*-PFGE is routinely used at the EURL for the surveillance of food, animals and environmental isolates at the national and European level \[[@B14],[@B15]\]. One of the main EURL activities is to develop or/and evaluate and keep up to date with new molecular subtyping methods and deploy them through the European NRL network. PFGE is widely acknowledged to be a time-consuming and labor-intensive method: the analyses are completed in 30 hours to three days from receipt of pure culture. It also requires highly skilled operators and does not offer commercially available standardized reagents. To consider a subtyping technique for *L. monocytogenes* as an alternative to PFGE, one of the first step is to test a panel of strains isolated not only from food and environment samples but also from human cases and to include outbreaks and reference strains \[[@B16]\].

Since 2008 the UK-NRL for *Listeria*has used fAFLP, with the enzyme pairs *Hind*III/*Hha*I, as the subtyping method for the routine surveillance of *L. monocytogenes* isolated from human clinical cases, food and food processing environments in the UK.

The objective of this study was to compare results obtained using fAFLP and PFGE, on a panel of *L. monocytogenes* isolates from human clinical cases, foods, food processing environments and animals. The panel included isolates known to be associated with outbreaks and sporadic cases of listeriosis, as well as reference strains, 3 of which were fully sequenced. The value of fAFLP for the routine subtyping of *L. monocytogenes*, in terms of its discriminatory ability and usefulness in detecting and investigating clusters of listeriosis cases for the NRLs, will be discussed.

Methods
=======

Strains
-------

This study included 109 isolates of *L. monocytogenes*: 47 from human cases of listeriosis, 56 from different food products and food processing environments, and 6 from animals. Strains in this study were selected to include those associated with listeriosis outbreaks as well as sporadic cases and were representative of the serogroups most often associated with human disease.

Forty nine isolates came from the UK-NRL: 35 were from UK clinical cases of listeriosis and 14 from foods and food processing environments isolated by UK-HPA Food Water and Microbiology Laboratories either as part of routine food sampling or in response to listeriosis investigations. One of the UK isolates from a clinical case of listeriosis was included in the study as duplicate culture (Table [1](#T1){ref-type="table"}).

###### 

**PFGE and fAFLP discriminatory ability using*Listeria monocytogenes*isolates of duplicate strains, associated with outbreaks or with sporadic cases**

          **Isolate**           **Test Study (TS) group number**\[[@B17]\]   **Responsible for sporadic (S) or outbreak (OB). Duplicate culture (D)**   **Origin of isolate**   **Country of origin**   **Molecular serogroup**^**1**^   ***PFGE***^***2***^***Apa*I*/Asc*I type**   **fAFLP**^***2***^***Hha*I/*Hind*III type**
  ---------------------------- -------------------------------------------- -------------------------------------------------------------------------- ----------------------- ----------------------- -------------------------------- ------------------------------------------- ---------------------------------------------
           10CEB565LM                              n/a                                                         OB 1                                             Human                  England                       IVb                                  326/136                                       IV4.3
           10CEB567LM                              n/a                                                         OB 1                                             Food                   England                       IVb                                  326/136                                       IV4.3
           10CEB550LM                              n/a                                                         OB 2                                             Human                  England                       IVb                                   178/6                                         I.8
           10CEB552LM                              n/a                                                         OB 2                                             Food                   England                       IVb                                   178/6                                         I.8
           10CEB553LM                              n/a                                                         OB 3                                             Human                  England                       IIa                                  149/109                                      III.10
           10CEB554LM                              n/a                                                         OB 3                                             Food                   England                       IIa                                  149/109                                      III.10
           10CEB559LM                              n/a                                                         OB 4                                             Human                  England                       IVb                                  309/142                                       UD4.1
           10CEB560LM                              n/a                                                         OB 4                                             Food                   England                       IVb                                  309/142                                       UD4.1
   10CEB542LM = 10CEB543LM^3^                      n/a                                                          D                                               Human                  England                       IIc                                  70/377                                       VIIc.8
              TS32                                  02                                                          S                                               Food                     USA                         IVb                                  180/50                                        I.67
              TS72                                  02                                                          S                                               Food                     USA                         IVb                                  180/50                                        I.67
         TS56 = TS77^3^                             03                                                      S^4^ and D                                          Human                    USA                         IIa                                  120/191                                      VIIa.27
              TS39                                  03                                                          S                                               Food                     USA                         IIa                                  120/191                                     VIIa.27a
              TS67                                  03                                                         S^4^                                             Human                    USA                         IIa                                  120/191                                     VIIa.27a
              TS17                                  05                                                          S                                               Human                    USA                         IIb                                  93/140                                       IVb.21
              TS61                                  05                                                          S                                               Food                     USA                         IIb                                  93/140                                       IVb.21
              TS31                                  15                                                         OB 5                                             Human                  France                        IVb                                  24-Dec                                        V.21
              TS69                                  15                                                         OB 5                                             Human                  France                        IVb                                  24-Dec                                        V.21
              TS21                                  16                                                         OB 6                                             Food                 Switzerland                     IVb                                   19/15                                         V.3
              TS55                                  16                                                         OB 6                                             Human                Switzerland                     IVb                                   19/15                                         V.3
              TS02                                  22                                                        S2^5^                                             Human                  England                       IIc                                   70/25                                       VIIc.1
              TS08                                  22                                                        S2^5^                                             Human                  England                       IIc                                   70/25                                       VIIc.1

^1^ Serogrouping performed by multiplex PCR \[[@B4]\]: results are from both the European Reference Laboratory (EURL) for *L. monocytogenes* and the UK National Reference laboratory (UK-NRL) for *Listeria.*

^2^ PFGE was performed by the EURL and fAFLP by UK-NRL.

^3^ Serogrouping and typing results were the same for each of the duplicate culture.

^4^ The 2 patients of TS group number 3 were 2 separate sporadic cases and not epidemiologically linked \[[@B18]\].

^5^ These 2 isolates are from the same patient who had 2 recurrent episodes of listeriosis \[[@B19]\].

n/a: not applicable.

Sixty one isolates came from the EURL: 35 were from foods and food processing environments collected from French food analysis laboratories in the context of monitoring, surveillance sampling or research projects and one was from an animal. Thirteen isolates labeled TS ("Test study"), 8 from human cases and 5 from foods, were from the WHO international multicenter *L. monocytogenes* subtyping study \[[@B17],[@B20]\]. One TS strain from a human case of listeriosis was included in this study as duplicate culture (Table [1](#T1){ref-type="table"}). Eleven isolates were reference strains including 8 CLIP strains and 3 fully sequenced strains (Table [2](#T2){ref-type="table"}).

###### 

**Origins and serogroups of 11*L. monocytogenes*reference strains used in this study**

      **Reference strains**       **EURL Strain number**   **Origin**    **Molecular serogroup**^**2**^
  ------------------------------ ------------------------ ------------- --------------------------------
          CLIP^1^ 74902                 00EB248LM            Animal                   IIa
            CLIP 74903                  00EB249LM            Animal                   IIb
            CLIP 74904                  00EB250LM             Human                   IIc
            CLIP 74905                  00EB251LM             Human                   IIa
            CLIP 74906                  00EB252LM             Human                   IIb
            CLIP 74907                  00EB253LM            Animal                   IIb
            CLIP 74910                  00EB256LM          Environment                IVb
            CLIP 74912                  00EB258LM            Animal                   IVb
               EGDe                        EGDe              Animal                   IIa
   (Accession number: AL591824)                                         
            \[[@B21]\]                                                                  
              F2365                       F2365               Food                    IVb
   (Accession number: AE017262)                                         
            \[[@B22]\]                                                                  
       CLIP80459 \[[@B23]\]             CLIP80459             Human                   IVb

^1^ CLIP: Pasteur Institute collection.

^2^ Serogrouping performed by multiplex PCR \[[@B4]\]: results are from both the European Reference Laboratory (EURL) for *L. monocytogenes* and the UK National Reference laboratory (UK-NRL) for *Listeria*.

Molecular serogrouping
----------------------

All the isolates were serogrouped by both laboratories using the multiplex PCR assay described by Doumith et al. (2004) \[[@B4]\] which clusters *L. monocytogenes* lineages I and II into four serogroups by amplification of four specific marker genes: *lmo*0737; *ORF*2110; *lmo*1118 and *ORF*2819.

Fluorescent AFLP
----------------

FAFLP was performed by the UK-NRL using a modified version of the protocol previously described by Desai and colleagues for *Campylobacter*\[[@B12]\]. Briefly, *Listeria* genomic DNA (15--50 ng) was digested with 5U each of two restriction enzymes, *Hind*III and *Hha*I (New England Biolabs) in the presence of RNase A and bovine serum albumin. Digests were ligated to two sets of double-stranded adapters. These adapters served as targets for an FAM-labeled Hind-A and a non-labeled Hha-A selective primer (Eurogentec, Seraing) for fragment amplification by PCR. The modified protocol consisted of a single digestion/ligation rather than 3 individual steps as previously described \[[@B12]\]. Fluorescent PCR products (amplified digested fragments) were separated on an ABI 3730XL 96 capillary DNA Analyzer (Applied Biosystems) alongside a GeneScan™- 600 LIZ® Size standard. Chromatographs showing FAM-fluorescing fragments were saved as fsa files, and were exported, visualized and analyzed using PEAK SCANNER™ v1.0 (Applied Biosystems). PEAK SCANNER™ also recorded the fragment data in a binary format in Excel files which were exported into BioNumerics v6.1, visualized as virtual electrophoresis gels and analyzed. The patterns determining the fAFLP types were identified using in-house BioNumerics and PEAK SCANNER™ libraries. Two profiles were considered to be different fAFLP types if they had at least one peak difference.

PFGE
----

All strains were characterized using the EURL protocol \[[@B14],[@B15]\] using the two restriction enzymes *Apa*I and *Asc*I. The laboratory has been accredited by the French Accreditation Committee, COFRAC for this PFGE method as an internal method (Accreditation No. 1--2246, Section Laboratories, <http://www.cofrac.fr>). Fragments obtained from the digestion by each of the enzymes were separated by gel electrophoresis. Gels were stained with ethidium bromide and banding patterns visualized under UV light, using the Gel Doc Eq system and Quantity One software (Bio-Rad). DNA patterns generated were analyzed with BioNumerics software (V 6.1, Applied Maths, Kortrijk, Belgium). Algorithms available within the program were used to compare patterns. For each enzyme, dendrograms were produced, using the Dice coefficient and UPGMA, with a 1% tolerance limit and 1% optimization. The dendrogam settings were chosen according to the PulseNet Europe recommendation \[[@B24]\]. Profiles were analyzed according to the standard operating procedure (SOP) developed at the EURL \[[@B15]\]. PFGE profiles were classified as different if there was at least one band different between them. Each PFGE profile was arbitrarily assigned a number.

Reproducibility of the subtyping methods
----------------------------------------

Two strains were included blindly as duplicates cultures (Table [1](#T1){ref-type="table"}).

Discriminatory power of the subtyping methods
---------------------------------------------

The ability of the two subtyping methods to discriminate *L. monocytogenes* strains was assessed in two ways:

\(1\) Determining the ability of the typing methods to recognize strains that are epidemiologically linked (Table [1](#T1){ref-type="table"}).

\(2\) Determining the ability of the typing methods to discriminate unrelated strains by calculating the Simpson's index of diversity (ID) \[[@B25]\]. The ID was calculated from PFGE and FAFP results of 97 isolates comprising field strains (75 isolates), references strains (11 isolates), sporadic cases and one representative isolate from each of the outbreaks shown in Table [1](#T1){ref-type="table"} (11 isolates).

Results
=======

Molecular serogrouping
----------------------

Molecular serogrouping results from the 109 isolates were concordant between the two testing laboratories and were as follows: 46 IIa strains; 12 IIb strains; 10 IIc strains; 40 IVb strains. One isolate did amplify in the multiplex PCR assay and was subsequently serotyped by conventional sero-agglutination by EURL as 4a strain. The 11 reference strains (8 CLIP and 3 fully sequenced strains) were found to belong to the expected serogroup (Table [2](#T2){ref-type="table"}).

In both laboratories, the same four serogroup IVb strains, displayed an unusual multiplex PCR profile to that usually observed with IVb strains, with an additional band due to the amplification of the *lmo*0737 gene fragment as previously described \[[@B26]\].

Subtyping data
--------------

Each fAFLP and PFGE type contained isolates belonging to only one of the 4 molecular serogroups, or serotype 4a, except for one PFGE type (81/194) which contained isolates from serogroups IIa and IIc (Figure [1](#F1){ref-type="fig"}).

![**Dendogram of similarity for 86*L. monocytogenes*isolates based on fAFLP type using the Dice coefficient and UPGMA.**](1471-2180-13-14-1){#F1}

Reproducibility and discriminatory power of the subtyping methods
-----------------------------------------------------------------

Table [1](#T1){ref-type="table"} shows the subtyping results of isolates used to evaluate the reproducibility, the discriminatory power and the ability to recognize same-type groups of isolates using PFGE and fAFLP. Isolates included in the study as duplicates gave indistinguishable fAFLP types and PFGE types (Table [1](#T1){ref-type="table"}). Table [1](#T1){ref-type="table"} also shows that distinct PFGE types and fAFLP types were observed in each groups of isolates associated with outbreak or sporadic cases, except for TS isolates group 03: PFGE type 120/191 was detected in *L. monocytogenes* TS67, TS56 (duplicate of TS77) and TS 39, but displayed two different fAFLP types *i.e.* VII.27 and VII.27a. These 2 fAFLP types were indistinguishable except for a small additional 'shoulder' after a double peak of 206 base pairs, as seen on the PeakScanner scan, present in strains TS39 and TS67 (type VIIa.27a) but not in isolate TS56 (type VIIa.27). To rule out any fluorescent artefacts, the 3 isolates were processed in triplicate on separate occasions and the fAFLP profile obtained by each replicate was always the same, including the 'shoulder' at 206 bp with strains TS39 and TS67.

Both subtyping methods separated the isolates into three distinct groups correlating with *L. monocytogenes* genetic lineages I, II and III (Figure [1](#F1){ref-type="fig"}; Figure [2](#F2){ref-type="fig"}; Figure [3](#F3){ref-type="fig"}). The 11 reference strains, including the 8 CLIP and the 3 fully sequenced strains, were classified by both fAFLP and PFGE, into the expected genetic lineages (Figure [1](#F1){ref-type="fig"}; Figure [2](#F2){ref-type="fig"}; Figure [3](#F3){ref-type="fig"}). The discriminatory power of fAFLP and PFGE was evaluated using 97 isolates including field strains, references strains, sporadic cases and representative isolates from each outbreak. The ID calculated from the typing results of fAFLP and PFGE is shown in Table [3](#T3){ref-type="table"}. The ID calculated from fAFLP typing was 0.993 and from PFGE typing 0.996. Both typing techniques were found to be more discriminatory for *L. monocytogenes* Lineage II than for those of lineage I.

![**Dendogram of similarity for 86*L. monocytogenes*isolates based on*Apa*I-PFGE type using the Dice coefficient and UPGMA.**](1471-2180-13-14-2){#F2}

![**Dendogram of similarity for 86*L. monocytogenes*isolates based on*Asc*I-PFGE type using the Dice coefficient and UPGMA.** H: human, F: food ; E: environment ; A: animal.](1471-2180-13-14-3){#F3}

###### 

**PFGE and fAFLP typing results from a panel of 97*L. monocytogenes*isolates with index of discrimination (ID)**

   ***L. monocytogenes*lineages**   **Serogroups**^**1**^**or serotype**^**2**^   **Number of isolates**   **Number of PFGE**^**3**^**types**   **PFGE ID**^**4**^   **Number of fAFLP**^**3**^**types**   **fAFLP ID**^**4**^
  -------------------------------- --------------------------------------------- ------------------------ ------------------------------------ -------------------- ------------------------------------- ---------------------
                 I                                      IVb                                 35                             36                         0.988                          33                           0.981
                IIb                                     11                                                                                                                                                
                 II                                     IIa                                 45                             45                         0.995                          43                           0.989
                IIc                                      5                                                                                                                                                
                III                                     4a                                  1                              1                           n/a                            1                            n/a
             **Total:**                               **97**                              **82**                       **0.996**                      **76**                      **0.993**               

^1^ Serogrouping performed by multiplex PCR \[[@B4]\]: results are from both the European Reference Laboratory (EURL) for *L. monocytogenes* and the UK National Reference laboratory (UK-NRL) for *Listeria.*

^2^ Based on sero-agglutination performed by EURL.

^3^*Apa*I/*Asc*I-PFGE was performed by the EURL and *Hind*III/*Hha*I-fAFLP by UK-NRL.

^4^ Index of discrimination calculated according to the Simpson's index of diversity (ID) \[[@B25]\]. n/a: not applicable.

Discussion
==========

The objective of this study was to compare fAFLP with PFGE for the subtyping of *L. monocytogenes*. The EURL for *L. monocytogenes* is the leader laboratory for improving or evaluate new typing methods and deploy them through the European NRL network. As well as comparing two subtyping methods, this study was also an opportunity to evaluate the inter-laboratory reproducibility of the multiplex PCR developed by Doumith et al. (2004) \[[@B4]\], to serogroup *L. monocytogenes.* The molecular serogrouping results of 109 isolates tested in this study were concordant between the two laboratories. The variant profile of serogroup IVb, characterized by the amplification of a supplementary gene fragment and previously described \[[@B26],[@B27]\], was identified in the same four isolates by both laboratories, demonstrating the reproducibility of the method.

PFGE is widely acknowledged to be a time-consuming and labor-intensive method: the analyses are completed in 30 hours to three days from receipt of pure culture. It also requires highly skilled operators and does not offer commercially available standardized reagents. FAFLP has some advantages over PFGE: results can be achieved within 48 hours; the method is easy to perform and is less-labor intensive. It enables a high sample throughput and is readily automatable and standardization can be facilitated by the use of commercially available reagents. The cost per isolate for both techniques was calculated by the EURL and UK-NRL and was found similar: PFGE €6.02 and fAFLP £3.26. One inconvenience of fAFLP is the use of a capillary electrophoresis system such as a DNA sequencer to enable amplified fragments to be sized rapidly and accurately. However, the method could easily be used by laboratories currently performing PFGE, even those without a capillary electrophoresis equipment as many commercial companies now provide fragment analysis as a standalone service. As well as PFGE results, FAFLP data are suitable for electronic transmission between laboratories. FAFLP profiles could be prone to subjective interpretation in a similar manner to PFGE profiles with the generation of large, double and uncertain peaks. This was found to be the case when fAFLP was used for subtyping *Salmonella enterica*\[[@B28]\]. Therefore the choice of restriction enzymes is important. For *L. monocytogenes*, the fAFLP protocol used here was based on the digestion of bacterial genome by the restriction enzymes *Hind*III and *Hha*I. This combination of enzymes generated profiles typically composed of between 50--80 fragments within a range of 60--600 bp, which were easily recognisable as fluorescent peaks on PEAK SCANNER™ chromatographs. The level of fluorescence sometimes varied between different batches of samples, but the number of peaks obtained by replicate samples in different batches was 100% reproducible. Therefore, the percentage of similarity between each fAFLP types selected was higher (100%) than chosen in previous works (\>95%) \[[@B11],[@B13]\].

The 109 isolates were divided by fAFLP and PFGE into three clearly distinguishable lineages. A similar division had previously been detected by fAFLP analyses with enzyme combinations other than those used in this study \[[@B9],[@B10]\]. This division correlates with the flagellar (H) antigen type which confirms the phylogenetic divergence between strains of serogroups IVb and IIb and those of serogroups IIa and IIc.

The subtyping results obtained in this study on a panel of *L. monocytogenes* field strains from human clinical cases, foods, food processing environments and animal cases, reference strains and isolates associated with outbreaks or sporadic cases showed equal discriminatory ability between fAFLP (ID 0.993) and *Apa*I/ *AscI*-PFGE (ID 0.996). Lomonaco et al. (2011) \[[@B13]\] also obtained similar discriminatory power between these 2 subtyping methods, but only on a panel of *L. monocytogenes* isolates from environmental and food sources. With other bacteria such as *Salmonella* and *E.coli* 0157, the discriminatory power of fAFLP was also found to be similar to PFGE \[[@B28]\].

In this study, isolates TS39 and TS67, produced a fAFLP profile indistinguishable from that produced by TS56 (duplicate of TS77), except for a small 'shoulder' after a specific double peak. The shoulder was not an artefact and appeared consistently, as shown by replicate testing. Because this difference was estimated as being 'less than a peak', all 4 isolates were assigned the same fAFLP type (VII.27) but for stringency purposes, the appendix 'a' was added to express the presence of the shoulder. These TS isolates were reported as a single type group (group 03) \[[@B17],[@B20]\] according to the same Multilocus Enzyme Electrophoresis type by Pinner et al. (1992) \[[@B18]\]. However, in a separate study, PFGE profiles performed with adifferent combination of enzymes (*Apa*I/ *Sma*I) than those used by the EURL, showed the 2 isolates TS39 and TS67 to be closely related but different from TS56 \[[@B5]\]. Since PFGE and fAFLP rely on the recognition of restriction sites and therefore detect genetic variations on sections of the whole bacterial genome, whole genome sequencing would be a method of choice to reveal the difference between these isolates.

Conclusions
===========

In conclusion the UK-NRL fAFLP protocol has been shown to be highly discriminatory, equal to that of the EURL PFGE protocol. FAFLP can be used for investigating outbreaks of human listeriosis and tracking the source of contamination in foods and food processing facilities. This study demonstrated that the fAFLP protocol used by UK-NRL is an ideal alternative to PFGE to subtype *L. monocytogenes.* However, before deploying fAFLP through the European NRL network, this method needs to be fully standardized and its reproducibility assessed by proficiency test trials. This would enable efficient comparison and interpretation of fAFLP data and an agreed assignment of fAFLP types in the future.
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